The compound displayed good selectivity for PDE4B (IC50 = 6–16 nM) and PDE4D (IC50 = 3–9 nM) isoforms, being a potential therapeutic agent for psoriasis and atopic dermatitis [97]. Here, PDE4D is linked to atopic eczema.